ONECUT1 and ONECUT2 have been reported in tumors: highly active ONECUT1 can suppress the proliferation and metastasis of colorectal and lung cancer cells (32, 33), whereas ONECUT2 acts as a survival factor and a driver of prostate cancer (34). Here, ONECUT1 is linked to lung carcinoma.